Caffeine and adenosine
- PMID: 20164566
- DOI: 10.3233/JAD-2010-1379
Caffeine and adenosine
Abstract
Caffeine causes most of its biological effects via antagonizing all types of adenosine receptors (ARs): A1, A2A, A3, and A2B and, as does adenosine, exerts effects on neurons and glial cells of all brain areas. In consequence, caffeine, when acting as an AR antagonist, is doing the opposite of activation of adenosine receptors due to removal of endogenous adenosinergic tonus. Besides AR antagonism, xanthines, including caffeine, have other biological actions: they inhibit phosphodiesterases (PDEs) (e.g., PDE1, PDE4, PDE5), promote calcium release from intracellular stores, and interfere with GABA-A receptors. Caffeine, through antagonism of ARs, affects brain functions such as sleep, cognition, learning, and memory, and modifies brain dysfunctions and diseases: Alzheimer's disease, Parkinson's disease, Huntington's disease, Epilepsy, Pain/Migraine, Depression, Schizophrenia. In conclusion, targeting approaches that involve ARs will enhance the possibilities to correct brain dysfunctions, via the universally consumed substance that is caffeine.
Similar articles
-
Caffeine, adenosine receptors, and synaptic plasticity.J Alzheimers Dis. 2010;20 Suppl 1:S25-34. doi: 10.3233/JAD-2010-091384. J Alzheimers Dis. 2010. PMID: 20182030 Review.
-
Adenosine receptor control of cognition in normal and disease.Int Rev Neurobiol. 2014;119:257-307. doi: 10.1016/B978-0-12-801022-8.00012-X. Int Rev Neurobiol. 2014. PMID: 25175970 Review.
-
Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.Handb Exp Pharmacol. 2011;(200):267-310. doi: 10.1007/978-3-642-13443-2_10. Handb Exp Pharmacol. 2011. PMID: 20859800 Review.
-
[Perspectives on the therapy of neuropsychiatric diseases with adenosinergic substances].Fortschr Neurol Psychiatr. 1995 Mar;63(3):93-8. doi: 10.1055/s-2007-996607. Fortschr Neurol Psychiatr. 1995. PMID: 7759049 Review. German.
-
Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.Handb Exp Pharmacol. 2009;(193):535-87. doi: 10.1007/978-3-540-89615-9_17. Handb Exp Pharmacol. 2009. PMID: 19639293 Review.
Cited by
-
The Association between Antenatal Tea Drinking and Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis.Epidemiologia (Basel). 2024 Apr 30;5(2):200-210. doi: 10.3390/epidemiologia5020014. Epidemiologia (Basel). 2024. PMID: 38804341 Free PMC article. Review.
-
Timing Matters: Time of Day Impacts the Ergogenic Effects of Caffeine-A Narrative Review.Nutrients. 2024 May 8;16(10):1421. doi: 10.3390/nu16101421. Nutrients. 2024. PMID: 38794659 Free PMC article. Review.
-
Assessment of Impact of Dietary Patterns on Obstructive Sleep Apnea Patients.Sleep Sci. 2024 Mar 26;17(1):e82-e89. doi: 10.1055/s-0043-1776745. eCollection 2024 Mar. Sleep Sci. 2024. PMID: 38545237 Free PMC article.
-
Daily Caffeine Consumption May Increase the Risk of Acute Kidney Injury Related to Platinum-Salt Chemotherapy in Thoracic Cancer Patients: A Translational Study.Nutrients. 2024 Mar 19;16(6):889. doi: 10.3390/nu16060889. Nutrients. 2024. PMID: 38542800 Free PMC article.
-
Evaluating the Neuroprotective Potential of Caffeinated Coffee in the Context of Aluminum-Induced Neurotoxicity: Insights from a PC12 Cell Culture Model.Antioxidants (Basel). 2024 Mar 13;13(3):342. doi: 10.3390/antiox13030342. Antioxidants (Basel). 2024. PMID: 38539875 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials